Giudice LC

No ORCID on file · 116 papers in corpus · active 1986-2026

Study types

  • article 47
  • review 24
  • other 12
  • preprint 4
  • rct 2

Condition tags

  • endometriosis 83
  • infertility 34
  • chronic_pelvic_pain 9
  • dysmenorrhea 7
  • adenomyosis 7
  • dyspareunia 2
2026
iScience ·doi:10.1016/j.isci.2026.114633

Recurrent pregnancy loss (RPL), defined as 2 or more pregnancy losses, affects 5-6% of ever-pregnant individuals. Approximately half of these cases have no identifiable explanation. In this study, we aim to identify diagnoses associated wit…

2026
Human reproduction (Oxford, England) ·doi:10.1093/humrep/deaf212

Study questionWhat is the recommended prevention, diagnosis, and treatment of infertility among individuals and couples?Summary answerThe World Health Organization (WHO) made 40 recommendations and six good practice statements for the preve…

review 2026
Current opinion in obstetrics & gynecology ·doi:10.1097/GCO.0000000000001099

PURPOSE OF REVIEW: Progesterone plays a pivotal role in implantation and ongoing pregnancy. In the context of assisted reproductive technology (ART), and in particular frozen embryo transfer (FET), increasing evidence suggests that serum pr…

other 2025
Cell reports methods ·doi:10.1016/j.crmeth.2025.101137

High-throughput sequencing enables efficient processing of DNA and RNA samples in batches, but batch effects can obscure true biological signal. We propose using anticlustering as an automated method to assign samples to balanced batches, m…

2025
·doi:10.1101/2025.03.03.641320

High throughput sequencing is a powerful tool for processing large amounts of DNA and RNA samples in batches. Proper experimental design and statistical methods are required to mitigate systematic technical factors due to differences in bat…

2025
F&S science ·doi:10.1016/j.xfss.2024.10.005

ObjectiveTo investigate if a positive result on ReceptivaDx for evaluation of B-cell lymphoma 6 (BCL6), a proposed marker of progesterone resistance associated with impaired uterine receptivity, correlates with a suboptimal profile of recep…

other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.05.28.656743

INTRODUCTION AND METHODS: Endometriosis has limited treatment options, prompting the search for novel therapeutics. We previously used a transcriptomics-based computational drug repositioning pipeline to analyze public bulk transcriptomic d…

other 2025
Cell reports. Medicine ·doi:10.1016/j.xcrm.2025.102245

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterog…

other 2025
medRxiv : the preprint server for health sciences ·doi:10.1101/2025.02.13.25322244

Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterog…

review 2025
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2024.08.043

Single-cell technologies are expanding our understanding of endometriosis and adenomyosis, which are sister disorders of the uterine endometrium that contain similar complements of lesion cell types but in different locations-outside and in…

preprint 2025
·doi:10.21203/rs.3.rs-7377239/v1

Abstract Although endometriosis is increasingly recognized as a risk factor for adverse pregnancy outcomes, large-scale analyses in U.S. populations remain limited. In this retrospective dual-cohort study, we analyzed over 4 million single…

review 2025
npj women's health ·doi:10.1038/s44294-024-00052-w

Endometriosis is an enigmatic disease whose diagnosis and management are being transformed through innovative surgical, molecular, and computational technologies. Integrating single-cell and other omic disease data with clinical and surgica…

other 2025
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2025.12.047
other 2024
iScience ·doi:10.1016/j.isci.2024.109388

Existing medical treatments for endometriosis-related pain are often ineffective, underscoring the need for new therapeutic strategies. In this study, we applied a computational drug repurposing pipeline to stratified and unstratified disea…

article 2023
Pain management ·doi:10.2217/pmt-2023-0052

WHAT IS THIS SUMMARY ABOUT?: This is a summary of research studies (known as clinical trials) called SPIRIT 1 and SPIRIT 2. The SPIRIT 1 and SPIRIT 2 studies compared how well a medicine called relugolix combination therapy worked in reliev…

other 2023
Fertility and sterility ·doi:10.1016/j.fertnstert.2023.04.021

OBJECTIVE: To determine whether B-cell lymphoma 6 (BCL6), an endometriosis-associated marker postulated to predict poor pregnancy outcomes, is differentially expressed in the window of implantation with various uterine preparation regimens …

meta-analysis 2023
Nature genetics ·doi:10.1038/s41588-023-01323-z

Endometriosis is a common condition associated with debilitating pelvic pain and infertility. A genome-wide association study meta-analysis, including 60,674 cases and 701,926 controls of European and East Asian descent, identified 42 genom…

preprint 2022
·doi:10.1101/2022.12.20.22283736

Abstract Endometriosis is a common, inflammatory pain disorder comprised of disease in the pelvis and abnormal uterine lining and ovarian function that affects ∼200 million women of reproductive age worldwide and up to 50% of those with pel…

article 2022
BMC medicine ·doi:10.1186/s12916-022-02359-4

Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…

preprint 2022
·doi:10.1101/2022.02.02.478809

Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…

rct 2022
Lancet (London, England) ·doi:10.1016/s0140-6736(22)00622-5

BACKGROUND: Endometriosis is a common cause of pelvic pain in women, for which current treatment options are suboptimal. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, combined with estradiol and a progestin, was eva…

article 2022
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2022.05.007

RESEARCH QUESTION: Adenomyosis is a common uterine disorder of uncertain causes. Can transcriptomic analyses of the endometrium and myometrium reveal potential mechanisms underlying adenomyosis pathogenesis? DESIGN: Transcriptomic profiles…

article 2022
Frontiers in immunology ·doi:10.3389/fimmu.2021.788315

The uterine lining (endometrium) exhibits a pro-inflammatory phenotype in women with endometriosis, resulting in pain, infertility, and poor pregnancy outcomes. The full complement of cell types contributing to this phenotype has yet to be …

other 2021
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.11.014

STUDY QUESTION: Can the priorities for future research in infertility be identified? SUMMARY ANSWER: The top 10 research priorities for the four areas of male infertility, female and unexplained infertility, medically assisted reproduction…

preprint 2021
·doi:10.1101/2021.08.27.457966

Abstract The uterine lining (endometrium) exhibits a pro-inflammatory phenotype in women with endometriosis, resulting in pain, infertility, and poor pregnancy outcomes. The full complement of cell types contributing to this phenotype has y…